-
Something wrong with this record ?
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs
D. Ustianenko, J. Pasulka, Z. Feketova, L. Bednarik, D. Zigackova, A. Fortova, M. Zavolan, S. Vanacova,
Language English Country England, Great Britain
Document type Journal Article
NLK
BioMedCentral Open Access
from 2012
PubMed Central
from 2010 to 1 year ago
ProQuest Central
from 2010-03-01 to 2018-12-31
Open Access Digital Library
from 2010-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2010-03-01 to 2018-12-31
- MeSH
- Cell Line MeSH
- Exoribonucleases genetics metabolism MeSH
- Immunoprecipitation MeSH
- Humans MeSH
- RNA, Untranslated metabolism MeSH
- Nucleotidyltransferases metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Uridylation of various cellular RNA species at the 3' end has been generally linked to RNA degradation. In mammals, uridylated pre-let-7 miRNAs and mRNAs are targeted by the 3' to 5' exoribonuclease DIS3L2. Mutations in DIS3L2 have been associated with Perlman syndrome and with Wilms tumor susceptibility. Using in vivo cross-linking and immunoprecipitation (CLIP) method, we discovered the DIS3L2-dependent cytoplasmic uridylome of human cells. We found a broad spectrum of uridylated RNAs including rRNAs, snRNAs, snoRNAs, tRNAs, vault, 7SL, Y RNAs, mRNAs, lncRNAs, and transcripts from pseudogenes. The unifying features of most of these identified RNAs are aberrant processing and the presence of stable secondary structures. Most importantly, we demonstrate that uridylation mediates DIS3L2 degradation of short RNA polymerase II-derived RNAs. Our findings establish the role of DIS3L2 and oligouridylation as the cytoplasmic quality control for highly structured ncRNAs.
Biozentrum University of Basel and Swiss Institute of Bioinformatics Basel Switzerland
CEITEC Central European Institute of Technology Masaryk University Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17031330
- 003
- CZ-PrNML
- 005
- 20171025115501.0
- 007
- ta
- 008
- 171025s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.15252/embj.201694857 $2 doi
- 035 __
- $a (PubMed)27647875
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Ustianenko, Dmytro $u CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 245 10
- $a TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs / $c D. Ustianenko, J. Pasulka, Z. Feketova, L. Bednarik, D. Zigackova, A. Fortova, M. Zavolan, S. Vanacova,
- 520 9_
- $a Uridylation of various cellular RNA species at the 3' end has been generally linked to RNA degradation. In mammals, uridylated pre-let-7 miRNAs and mRNAs are targeted by the 3' to 5' exoribonuclease DIS3L2. Mutations in DIS3L2 have been associated with Perlman syndrome and with Wilms tumor susceptibility. Using in vivo cross-linking and immunoprecipitation (CLIP) method, we discovered the DIS3L2-dependent cytoplasmic uridylome of human cells. We found a broad spectrum of uridylated RNAs including rRNAs, snRNAs, snoRNAs, tRNAs, vault, 7SL, Y RNAs, mRNAs, lncRNAs, and transcripts from pseudogenes. The unifying features of most of these identified RNAs are aberrant processing and the presence of stable secondary structures. Most importantly, we demonstrate that uridylation mediates DIS3L2 degradation of short RNA polymerase II-derived RNAs. Our findings establish the role of DIS3L2 and oligouridylation as the cytoplasmic quality control for highly structured ncRNAs.
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a exoribonukleasy $x genetika $x metabolismus $7 D005095
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoprecipitace $7 D047468
- 650 _2
- $a nukleotidyltransferasy $x metabolismus $7 D009713
- 650 _2
- $a nekódující RNA $x metabolismus $7 D022661
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pasulka, Josef $u CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Feketova, Zuzana $u CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Bednarik, Lukas $u CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Zigackova, Dagmar $u CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic. National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Fortova, Andrea $u CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Zavolan, Mihaela $u Biozentrum, University of Basel and Swiss Institute of Bioinformatics, Basel, Switzerland.
- 700 1_
- $a Vanacova, Stepanka $u CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic stepanka.vanacova@ceitec.muni.cz.
- 773 0_
- $w MED00181668 $t The EMBO journal $x 1460-2075 $g Roč. 35, č. 20 (2016), s. 2179-2191
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27647875 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171025115543 $b ABA008
- 999 __
- $a ok $b bmc $g 1254923 $s 992357
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 35 $c 20 $d 2179-2191 $e 20160919 $i 1460-2075 $m The EPMA journal $n EPMA J $x MED00181668
- LZP __
- $a Pubmed-20171025